Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.05 (overall 0.03) | 0.05 |
| cell type Human Protein Atlas | cell type enhanced in brain excitatory neurons (503 nCPM) | 1.00 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 20 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 6345
Sealed predictions
- OLFM3 in dopamine neurons, braak+0.55 (p 0.122) → +0.05 (p 0.893)receipt 6353
Swarm cases
receipt 6353: OLFM3 in dopamine neurons, braak
- power
- full sample +0.41 (p 0.089, n 18), 95% CI -0.07 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.41 (p 0.089, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.40 (p 0.101, n 18). could be the mix.
- skeptic
- leave-one-out range +0.33 to +0.59, sign flips 0; without severely affected donors +0.41 (p 0.089, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for OLFM3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts